Blood Markers Help Predict MS Disease Progression
Meeting Coverage > > ECTRIMS-- Patients with high NfL at illness beginning might take advantage of high-efficacy treatments
by Judy George, Deputy Managing Editor, MedPage Today September 19, 2024
Blood biomarkers at illness beginning might assist anticipate relapse-associated intensifying and development independent of regression activity (PIRA) in several sclerosis (MS), an observational research study recommended.
Serum levels of neurofilament light (NfL), a marker of axonal injury, forecasted both relapse-associated worsening and PIRA, reported Enric Monreal, MD, PhD, of the Hospital Universitario Ramón y Cajal in Madrid, who provided the ...